Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Aug 16, 2021; 9(23): 6916-6921
Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6916
Table 1 Clinical data of eight patients with dopamine agonist responsive burning mouth syndrome
Patient
Sex
Age (yr)
Duration of BMS (mo)
Involved sites
Clinical manifestation
VAS score
Concurrent RLS
Family history of BMS or RLS
Maintenance dose of pramipexole
Time required to achieve significant effect
1F5324Anterior 2/3 of the tongue, hard palate, lipOral burning pain, ant walking sensation, dry mouth symptom6YN0.25 mg/d2 wk
2F5830Anterior 2/3 of the tongue, hard palate, buccal mucosaOral burning pain, numbness, dry mouth symptom8YN0.375 mg/d4 wk
3M4912Anterior 2/3 of the tongue, hard palate, lipOral burning pain, dry mouth symptom7NOne brother with RLS0.25 mg/d4 wk
4M6536Anterior 2/3 of the tongue, hard palate, soft palate, buccal mucosaOral burning pain, ant walking sensation, dry mouth symptom, taste disturbance8NN0.5 mg/d5 wk
5F6242Anterior 2/3 of the tongue, hard palate, soft palate, lip, buccal mucosa, larynxOral burning pain, numbness, dry mouth symptom10YOne brother with RLS0.5 mg/d8 wk
6M4624Anterior 2/3 of the tongue, hard palate, lipOral burning pain, numbness7NOne sister with BMS0.25 mg/d4 wk
7F5530Anterior 2/3 of the tongue, hard palate, soft palate,buccal mucosaOral burning pain, dry mouth symptom9NN0.375 mg/d6 wk
8F5712Anterior 2/3 of the tongue, lip, buccal mucosaOral burning pain, numbness, dry mouth symptom7YN0.25 mg/d3 wk